<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00149877</url>
  </required_header>
  <id_info>
    <org_study_id>CHTF919EHK01</org_study_id>
    <nct_id>NCT00149877</nct_id>
  </id_info>
  <brief_title>Efficacy, Safety and Tolerability of Tegaserod in Patients With Chronic Constipation</brief_title>
  <official_title>Efficacy, Safety and Tolerability of Tegaserod in Patients With Chronic Constipation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Novartis</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Novartis</source>
  <brief_summary>
    <textblock>
      Tegaserod (HTF919) is an aminoguanidine indole compound and a member of a new class of
      subgroup-selective 5-hydroxytryptamine (5-HT) agonists. The aim of this study is to
      investigate the efficacy, safety and tolerability of tegaserod on bowel habits in patients
      with CC.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>April 2004</start_date>
  <completion_date type="Actual">February 2006</completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Number of complete spontaneous bowel movement (csbm) during the first 4 weeks of treatment.</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Number of csbm during 8 weeks of treatment.</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Daily assessment of bowel habits:frequency, form, straining, feeling of complete evacuation.</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Daily patients' assessment: bowel habits, constipation, distention/bloating, abdominal discomfort pain.</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Laxative use.</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Safety and tolerability.</measure>
  </secondary_outcome>
  <enrollment>250</enrollment>
  <condition>Chronic Constipation</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Tegaserod</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Male and females of at least 18 years of age

          -  A 12-month history of constipation (defined as &lt; three spontaneous bowel movements per
             week and â‰¥1 of the following symptoms &gt;25% of the time: hard stools, sensation of
             incomplete evacuation and straining)

        Exclusion Criteria:

          -  Patients with cancer, inflammatory bowel disease or other structural bowel disease

          -  Patients who participated in a prior tegaserod study

          -  Evidence of cathartic colon or laxative abuse, pelvic floor dysfunction or
             neurological disorders

        Other protocol-defined inclusion/exclusion criteria may apply.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
  </eligibility>
  <overall_official>
    <last_name>Novartis</last_name>
    <role>Study Chair</role>
    <affiliation>Basel</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Novartis</name>
      <address>
        <city>Basel</city>
        <zip>4056</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>January 2008</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>September 6, 2005</study_first_submitted>
  <study_first_submitted_qc>September 6, 2005</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 8, 2005</study_first_posted>
  <last_update_submitted>January 31, 2008</last_update_submitted>
  <last_update_submitted_qc>January 31, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">February 1, 2008</last_update_posted>
  <keyword>Chronic constipation, tegaserod</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Constipation</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Tegaserod</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

